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Objective: To compare walking test results with walking
in daily life, and to investigate the relationships between
walking tests, walking activity in daily life, and perceived
mobility problems in patients with post-poliomyelitis syn-
drome.
Subjects: Twenty-four ambulant patients with post-polio-
myelitis syndrome.
Methods: Walking tests were performed at self-preferred
and maximal speed. Walking activity was measured with an
ambulatory activity monitor. Heart rate, step cadence and
walking speed in the test and in daily life were compared.
Walking speed in daily life was represented by the intensity
of walking. Perceived mobility problems were assessed with
the Nottingham Health Profile.
Results: Heart rate during walking was lower in the test
at self-preferred speed than in daily life (mean difference:
11.3 ± 10.4; p = 0.001). Self-preferred walking speed in the
test and in daily life correlated significantly (r = 0.55;
p = 0.04). In a sub-group with a test performance below the
median value, test performance correlated significantly with
walking activity. No significant correlation was found
between perceived mobility problems and walking activity.
Conclusion: Walking in daily life may be more demanding
than walking under standardized conditions. Patients with
post-poliomyelitis syndrome with the lowest test perfor-
mance walked less in daily life. Patients do not necessarily
match their activity pattern to their perceived mobility
problems.
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INTRODUCTION
Paralytic poliomyelitis most often affects the muscles of the
lower extremities. As a consequence, many individuals with late
onset polio sequelae report a decline in walking ability (1, 2).
Limitation in walking activity is one of the most prominent
problems of patients with post-poliomyelitis syndrome (PPS)
(3–5).
Walking capacity has been reported as an indicator of
performance and activities of daily living in patients with PPS
(4, 6–9). Frequently used methods to measure walking perfor-
mance are time-scored tests at maximal or self-preferred walk-
ing speed, usually carried out in a clinical setting (4, 7, 8). These
standardized performance tests measure various aspects of
walking, such as speed, distance and physical effort.
Walking at comfortable speed in a clinical setting is assumed
to represent walking in daily life (10, 11). However, the level of
effort and the characteristics of walking, such as speed and step
cadence, during walking tests under standardized conditions
may differ from those of walking in daily life, when conditions
are not standardized.
Therapeutic interventions for polio patients may aim at
increasing their walking ability. It can be questioned whether
walking ability in daily life, and changes in it, can be measured
with walking tests. It seems likely that a relationship exists
between walking test performance and the amount of walking
in daily life (12). However, this relationship has never been
investigated in patients with PPS. We hypothesized that walking
test performance is an indicator of the amount of walking in
daily life.
In patients with PPS, perceived physical mobility problems
were found to be related to performance in walking tests (4).
However, it is unknown whether perceived mobility problems
also imply that there is less actual walking activity. Therefore, it
is important to investigate the relationship between perceived
physical mobility problems and actual walking in daily life.
Recently, we carried out a study to investigate the effects
of pyridostigmine on fatigue in PPS patients (13). In that study,
walking tests were performed at self-preferred and maximal
speed, and the amount of walking in daily life was measured
with an activity monitor (14). The activity monitor allows long-
term (48 hours) continuous measurement of daily activities and
physical effort with minimal influence on behaviour. Perceived
physical mobility problems were also measured in this study
with a validated questionnaire.
The purpose of the present study was threefold: (i) to
investigate whether walking at self-preferred speed in a clinical
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setting reflects the levels of effort and characteristics of normal
walking in the actual circumstances of daily life; (ii) to inves-
tigate whether the performance in walking tests is related to
the amount of walking in daily life; and (iii) to investigate the
relationship between perceived physical mobility problems and
the amount of walking in daily life.
METHODS
The data were derived from the measurements of 24 patients with PPS
(4 men and 20 women) consecutively included in the pyridostigmine
trial, who underwent ambulatory monitoring of their daily life activities
(13). The mean age of these patients was 54.5 (SD 8.9) years. PPS
symptoms had existed for an average of 10.9 (SD 7.7) years, and all
patients had new muscle weakness in at least 1 leg. All patients were able
to walk for at least 2 minutes at self-preferred speed. Walking aids and
orthopaedic devices were used in the walking tests in the same way in
which they were used when walking outdoors. Nine patients used some
type of walking aid (canes, crutches, orthosis).
Outcome measures
Walking tests. Two tests were performed on a closed, marked 65-metre
indoor, oval-shaped track. The patients first walked for 2 minutes at self-
preferred speed and the distance was measured. They then walked 75
metres at maximal speed (without running) and the time was recorded.
Each test was started after the patient had rested for 5 minutes, sitting on
a chair. For each test, the mean walking speed was calculated from the
distance and the time. When walking at self-preferred speed, the
patient’s heart rate was measured every 5 seconds with a Polar
Sporttester (Polar Vantage NV with Advantage Interface System; Polar
Electro Nederland BV, Almere, The Netherlands). Mean steady state
heart rate was calculated from the recording period between 70 and 90
seconds after the patient had started walking.
When walking at self-preferred speed, a unilateral surface electro-
myography (EMG) of the patient’s quadriceps muscles was recorded
with a portable ME300 Muscle Tester (ME300 Muscle Tester, 2-
channel; Mega Electronics Ltd., Kuopio, Finland). Disposable surface
electrodes (Medi-Trace Pellet, self-adhesive Ag/AgCl ECG electrodes;
surface: 1 cm2, centre-to-centre distance: 31 mm) were placed over the
vastus lateralis. Over the same period that was used to calculate the mean
heart rate, the step cadence was determined from the peak amplitudes in
the EMG signal (15).
Walking in daily life. The activity monitor, described in detail by
Bussmann et al. (14), is based on long-term accelerometry. Signals from
piezo-resistive accelerometers attached to the thighs and trunk were
continuously measured and stored (32 Hz) on a portable data-recorder.
Data from ECG were recorded simultaneously. The patients’ data were
recorded for a period of 48 hours in their regular daily life environment.
After downloading the stored data onto a computer, several body
postures and motions (walking included) were automatically detected
from the accelerometer signals (Vitagraph, Temec Instruments BV,
Kerkrade, The Netherlands). The duration of walking was calculated
as the percentage of time that a patient demonstrated walking activity
(defined as walking for at least 5 seconds) in the 48-hour recording
period. In addition, “longer walking” was determined as the duration of
walking continuously for at least 30 seconds, and was expressed as a
percentage of the 48 hours.
Four walking periods of at least 120 seconds were selected to
determine steady state heart rate, step cadence and motility (which is
an indicator of walking speed). Patients had not performed strenuous
activities in the 60 seconds before the start of these walking periods. The
time-span between 2 periods was a minimum of 60 minutes. Values were
calculated from the recording interval between 70 and 90 seconds after
the onset of walking, and were averaged over the 4 walking periods.
Heart rate was extracted from electrocardiographic data (16), and
cadence was extracted from the pattern of the accelerometry data
recorded from the thighs. Motility expresses the intensity of the accelero-
metry data. Its value depends on the variability of the accelerometer
signal around the mean, i.e. the amplitudes of the peaks and the
frequency of occurrence of these peaks (14). It has been shown that a
strong relationship exists between motility and walking speed, and that
this relationship is independent of the efficiency of walking (16, 17).
Perceived physical mobility problems. Perceived mobility problems
were assessed with the Physical Mobility category of a validated Dutch
version of the Nottingham Health Profile (NHPPM) (18). The NHPPM
score was calculated as the percentage of the 8 items answered with
“yes” (a perceived problem).
The walking tests were performed and the NHP was administered
during the second pre-medication study visit to the hospital (13). Within
7 days after the hospital visit, walking in daily life was measured with the
activity monitor.
Statistics
Walking test results and walking in daily life were compared with
respect to heart rate, cadence and walking speed, by means of t–tests or
Pearson’s correlation coefficient. The within-subject variability of heart
rate, cadence and motility during walking in daily life over the 4 periods
was determined with the coefficient of variation (19), calculated as:
subject in
pi
pi
 100
 
n, with ( pi) as the standard deviation and
pi as the mean of the 4 periods of subject i, and n as the total number of
subjects.
The relationships between walking speed in the walking tests and
the duration of walking and the duration of longer walking in daily life
were analysed by calculating Pearson’s correlation coefficients. Relation-
ships were studied for all patients, and for sub-groups, based on the
median value of the walking test results, i.e. patients with a walking per-
formance below the group median value and patients with a walking
performance above the group median value.
Relationships between perceived physical mobility problems and
walking in daily life and walking test results were analysed by cal-
culating Spearman’s correlation coefficients. The significance level was
set at alpha 0.05. Statistical analysis was performed with the SPSS
10.0.5 software package (SPSS Inc., Chicago, Illinois, USA).
RESULTS
For the test at self-preferred speed, the mean walking speed was
1.02 (SD 0.17) metres/second, which was significantly lower
(p 0.01) than the walking speed of 1.32 (SD 0.24) metres/
second in the maximal test (mean difference: 0.31 (SD 0.16);
95%CI: 0.24–0.37). Walking at self-preferred and maximal
speed correlated significantly (r = 0.75, p 0.01). For walking
in daily life, the correlation between the duration of walking
(6.6%) and the duration of longer walking (2.9%) was r = 0.89
(p 0.01).
Only 14 patients had walked at least 4 periods with a minimal
duration of 120 seconds. The coefficient of variation (SD) over
these 4 periods was 5.1% (2.0) for heart rate, 3.0% (1.9) for
cadence and 7.8% (2.5) for motility.
Characteristics of walking in the test at self-preferred speed
compared with walking in daily life
The mean heart rate in the walking test at self-preferred
speed was significantly lower than when walking in daily life
(p 0.01) (Table I). There was no difference between the
cadence in the walking test and the cadence when walking in
daily life. The correlation between cadence in the test and in
daily life was r = 0.46 (n.s.). The correlation between walking
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speed in the test and motility of walking in daily life was r = 0.55
(p = 0.04).
Relationship between walking test performance and the
duration of walking in daily life
Both self-preferred and maximal speed in the walking tests
correlated significantly with the duration of walking and longer
walking in daily life (Table II). The strongest correlation was
found between self-preferred speed and walking duration
(r = 0.52, p 0.01).
For the sub-group with walking test results below the median
value of the total group, significant correlations were found
between walking test performance and walking activity in daily
life. No significant correlations between walking test perfor-
mance and walking activity in daily life were found for the
sub-group with the better test performance results.
Relationship between perceived physical mobility problems
and walking activity in daily life
The median (25–75 percentile) score on the NHPPM was 25
(16–50). The NHPPM correlated with the walking test perfor-
mance for both self-preferred and maximal speed (Table III).
The NHPPM did not correlate with the duration of walking or
with longer walking in daily life.
DISCUSSION
The aim of the present study was to investigate the relation-
ships between clinical walking tests, walking in daily life and
perceived physical mobility problems in patients with PPS.
Specifically patients with PPS were studied because they demon-
strate an increase in neuromuscular symptoms and perceive a
decline in walking ability (4, 10).
It appeared that walking in daily life differed from walking
under standardized conditions: the heart rate was significantly
higher in daily life than in a test at self-selected speed. This may
be due to the less straining conditions during the walking test:
the walking surface is flat and level, no additional tasks have
to be performed, and there are no weather influences. This is
in contrast with a study in patients with chronic obstructive
pulmonary disease, in which no difference was found in walking
speed and heart rate between an indoor and outdoor 6-minute
walking test (20). However, the outdoor test in that study was
performed under optimal conditions (a flat sidewalk in a quiet
neighbourhood) and no additional tasks were carried out.
The higher heart rate in daily life in the present study may also
be due to carry-over effects from previous activities. Although
the walking periods from which the heart rate was determined
with the activity monitor were all preceded by a period of
relative rest, the walking tests were always preceded by a
standardized period of absolute rest (5 minutes of sitting on
a chair).
In contrast with heart rate, no systematic difference was found
between cadence in the walking test at self-preferred speed and
cadence when walking in daily life. However, the large standard
deviation of the mean difference and the lack of correlation
Table I. Results of the walking test at self-preferred speed and walking in daily life. The means (SD) are given for the outcome measures
Walking test at
self-preferred speed
Walking in
daily life
Mean
difference 95% CI; p-value
Speed (metres/second) (n = 24) 1.02 (0.17)
Duration of walking (% time) 6.6 (2.7)
Duration of walking 30 seconds (% time) 2.9 (1.7)
Heart rate (beats/minute) (n = 14) 98.6 (9.2) 110.0 (14.0) 11.3 (10.4) 5.4–17.3; p 0.01
Cadence (steps/minute) 107.6 (10.0) 109.1 (6.6) 1.5 (9.1) 3.8–6.8; p = 0.55
Speed (metres/second) 1.08 (0.14)
Motility (g) 0.23 (0.03)
1 g is 9.8 ms2.
Table II. Relationship between walking test performance and the
duration of walking in daily life. For further information see
Methods.
Walking in daily life
Walking test performance
Walking
duration
Walking
duration 30 s
Self-preferred speed (n = 24) 0.52** 0.50*
sub-group low speed 0.65* 0.59*
sub-group high speed 0.27 0.24
Maximal speed (n = 24) 0.42* 0.46*
sub-group low speed 0.73** 0.81**
sub-group high speed 0.27 0.60*
Pearson’s correlation coefficients are presented. Sub-groups were
formed, based on the median value of the walking test results.
Median values for self-preferred speed and maximal speed
were 1.05 metres/second and 1.29 metres/second, respectively.
*p 0.05; **p 0.01.
Table III. Relationship between perceived physical mobility
problems, and duration of walking in daily life and walking test
performance (n = 24). For further information see Methods.
Walking in daily life NHPPM
Walking duration 0.29
Walking duration 30 seconds 0.15
Walking test performance
Self-preferred speed 0.70**
Maximal speed 0.69**
Spearman’s correlation coefficients are presented. NHPPM = Not-
tingham Health Profile, category Physical Mobility. *p 0.05;
**p 0.01.
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between the cadence in the walking test and in daily life indicate
large within-subject variability between the 2 conditions. The
small coefficient of variation (3%) for cadence in daily life
suggests that this is not due to large within-subject variability of
walking in daily life. It seems that the individual cadence when
walking in the test differs from cadence when walking in daily
life, but in different directions among patients. The cause of this
remains speculative.
Both self-preferred walking speed and maximal walking
speed were comparable to what has been found in an earlier
study focusing on patients with PPS (21). The walking speed of
patients with PPS is noticeably lower than that of healthy
subjects (22). The percentage of walking activity in daily life of
patients with PPS (6.6%) has also been found to be less than that
of healthy subjects (9.1%), but higher than that of patients with
chronic congestive heart failure (3.4%) (23).
In the present study, significant relationships were found
between walking test performance and the amount of walking
in daily life. However, walking performance at self-preferred
speed explained only 27% (r2 = 0.522; Table II) of the variance
in duration of walking in daily life. This illustrates that actual
walking in daily life is not only determined by walking ability. It
is likely that daily life behaviour is largely determined by social
behaviour, personal lifestyle, working conditions and living
circumstances, such as the localization of shops, etc.
Interestingly, much stronger relationships between walking
test performance and walking in daily life were found for those
patients with PPS with lower walking ability in the tests.
Apparently, actual walking behaviour in these patients is mainly
determined by their reduced walking ability. This is best illus-
trated by the variance in longer walking duration (30 seconds)
that is explained for 66% (r2 = 0.812; Table II) by the per-
formance in the maximal walking test. Maximal walking speed
is apparently a better indicator of capacity than self-preferred
walking speed for prolonged walking.
One limitation of measuring behaviour is the day-to-day
variability in daily life activities (23). Single-day measurements
are probably not representative for a “general” level of daily
activities. An attempt was made to take this into account by
measuring for a period of 48 hours. However, it is still possible
that variability between days may have affected some of the
relationships found in this study.
Both self-preferred and maximal speed in the walking tests
were significantly related to perceived physical mobility prob-
lems. This is in agreement with the results of a study carried
out by Nollet et al. in a different group of polio patients (4).
Surprisingly, no significant relationships were found between
perceived physical mobility problems and walking duration in
daily life. This is in line with the results of a study carried out
by Willen et al., who found no significant relationship between
the score on the Physical Activity Scale for the Elderly and
the score on the NHPPM in patients with PPS (10). The lack
of correlation between perceived physical mobility problems
and walking in daily life might reflect the fact that certain
tasks simply have to be performed in daily life, despite
perceived limitations in physical performance. It is well known
that patients with PPS tend to ignore or even deny their dis-
abilities (24).
In conclusion, the cardiac response of patients with PPS
during walking in daily life was significantly higher than during
walking in test circumstances. It may be that walking tests at
self-preferred speed tend to under-estimate the physical effort
of walking in daily life. Test performance was related to walking
in daily life, and this relationship was most pronounced for
those with the lowest test performance. Apparently, the limited
capacity of these patients largely determined their physical
behaviour. Although perceived physical mobility problems
were related to walking test performance, they were not related
to walking behaviour in daily life. This indicates that patients
with PPS do not necessarily adapt their behaviour to their per-
ceived capacities. Ambulatory monitoring of daily activities
may be helpful in future studies that focus on changing actual
behaviour in daily life.
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